Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin for Prevention of Type 2 Diabetes in Women with Recent Gestational Diabetes
NCT01018602Phase 2Unknown
- Sponsor
- Institut für Diabetesforschung
- Start
- Jan 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Institut für Diabetesforschung. Status: unknown.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01018602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018602.